Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
15
RLXXF Quote, Financials, Valuation and Earnings
Last price:
$31.2000
Seasonality move
:
0.58%
Day range:
$29.7810 - $31.3090
52-week range:
$26.9430 - $57.0090
Dividend yield:
2.74%
P/E ratio:
21.11x
P/S ratio:
4.60x
P/B ratio:
29.35x
Volume:
7.5K
Avg. volume:
16.3K
1-year change:
-41.38%
Market cap:
$56.4B
Revenue:
$12.6B
EPS (TTM):
$1.48
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10B | $10.5B | $11.4B | $12.1B | $12.6B | |
| Revenue Growth (YoY) | 9.27% | 5.75% | 8.09% | 5.86% | 4.84% | |
| Cost of Revenues | $3.9B | $4.1B | $4.3B | $4.5B | $4.6B | |
| Gross Profit | $6B | $6.4B | $7B | $7.5B | $8.1B | |
| Gross Profit Margin | 60.53% | 60.96% | 61.85% | 62.29% | 63.7% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.7B | $4.1B | $4.2B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.5B | $3.5B | $3.7B | $3.8B | $4.1B | |
| Operating Income | $2.5B | $2.9B | $3.3B | $3.7B | $3.9B | |
| Net Interest Expenses | $171.9M | $224.2M | $372.9M | $359.1M | $392.7M | |
| EBT. Incl. Unusual Items | $2.4B | $2.6B | $2.8B | $3.2B | $3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $448.3M | $592.5M | $630.2M | $783.3M | $885.6M | |
| Net Income to Company | $2.6B | $2.9B | $3.3B | $3.7B | $4B | |
| Minority Interest in Earnings | -- | -$2.5M | $8.7M | $12.8M | $17.1M | |
| Net Income to Common Excl Extra Items | $2B | $2B | $2.2B | $2.5B | $2.7B | |
| Basic EPS (Cont. Ops) | $1.05 | $1.05 | $1.17 | $1.32 | $1.48 | |
| Diluted EPS (Cont. Ops) | $1.04 | $1.04 | $1.16 | $1.32 | $1.48 | |
| Weighted Average Basic Share | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | |
| EBITDA | $3.5B | $3.9B | $4.3B | $4.7B | $4.9B | |
| EBIT | $2.5B | $2.9B | $3.3B | $3.7B | $3.9B | |
| Revenue (Reported) | $10B | $10.5B | $11.4B | $12.1B | $12.6B | |
| Operating Income (Reported) | $2.5B | $2.9B | $3.3B | $3.7B | $3.9B | |
| Operating Income (Adjusted) | $2.5B | $2.9B | $3.3B | $3.7B | $3.9B | |
| Period Ending | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.9B | $2B | $2.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | $3M | -$8M | -$32.5M | |
| Operating Expenses | -- | -- | $6.6M | $7.5M | $8.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | $7.7M | $8.4M | $7.3M | |
| EBT. Incl. Unusual Items | -- | -- | $60.8M | $382.6M | $237.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$9.1M | $39.7M | $46.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $69.9M | $342.9M | $190.9M | |
| Basic EPS (Cont. Ops) | -- | -- | $1.71 | $8.42 | $4.78 | |
| Diluted EPS (Cont. Ops) | -- | -- | $1.70 | $8.39 | $4.77 | |
| Weighted Average Basic Share | -- | -- | $40.9M | $40.7M | $39.9M | |
| Weighted Average Diluted Share | -- | -- | $41.1M | $40.9M | $40M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | $68.5M | $391M | $244.3M | |
| Revenue (Reported) | -- | -- | $1.9B | $2B | $2.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | $68.5M | $391M | $244.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10B | $10.5B | $11.4B | $12.1B | $12.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.9B | $4.1B | $4.3B | $4.5B | $4.6B | |
| Gross Profit | $6B | $6.4B | $7B | $7.5B | $8.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.7B | $4.1B | $4.2B | $2.2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.5B | $3.5B | $3.7B | $3.8B | $4.1B | |
| Operating Income | $2.5B | $2.9B | $3.3B | $3.7B | $4B | |
| Net Interest Expenses | $194M | $244.5M | $401.9M | $388.8M | $389.8M | |
| EBT. Incl. Unusual Items | $2.4B | $2.6B | $2.8B | $3.2B | $3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $448.5M | $593.9M | $630M | $783.2M | $887M | |
| Net Income to Company | $2.6B | $2.9B | $3.3B | $3.7B | $4.1B | |
| Minority Interest in Earnings | -$78.3K | -$2.5M | $8.8M | $12.9M | $17.3M | |
| Net Income to Common Excl Extra Items | $2B | $2B | $2.2B | $2.5B | $2.7B | |
| Basic EPS (Cont. Ops) | $1.05 | $1.05 | $1.17 | $1.32 | $1.49 | |
| Diluted EPS (Cont. Ops) | $1.05 | $1.04 | $1.16 | $1.32 | $1.48 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.5B | $3.9B | $4.3B | $4.7B | $5B | |
| EBIT | $2.5B | $2.9B | $3.3B | $3.7B | $4B | |
| Revenue (Reported) | $10B | $10.5B | $11.4B | $12.1B | $12.6B | |
| Operating Income (Reported) | $2.5B | $2.9B | $3.3B | $3.7B | $4B | |
| Operating Income (Adjusted) | $2.5B | $2.9B | $3.3B | $3.7B | $4B | |
| Period Ending | 2022-02-14 | 2023-02-14 | 2024-02-14 | 2025-02-14 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $153.1M | $401.8M | $197.6M | $149M | $176.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.2B | $2.5B | $2.6B | $2.7B | $3.3B | |
| Inventory | $342.7M | $371.7M | $405.4M | $414.5M | $418.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.2B | $3.7B | $3.6B | $3.8B | $4B | |
| Property Plant And Equipment | $395.5M | $326M | $270.3M | $214.2M | $213.9M | |
| Long-Term Investments | $383.3M | $363.3M | $411.8M | $395.8M | $489.6M | |
| Goodwill | $9.9B | $10.2B | $10.2B | $10.3B | -- | |
| Other Intangibles | $4.5B | $4.3B | $4.1B | $4B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $18.8B | $19B | $19B | $19B | $19.8B | |
| Accounts Payable | $147.6M | $155.2M | $218M | $279.3M | $5.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $81.1M | $72.6M | $47.7M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.1B | $6.2B | $7B | $7.2B | $8.1B | |
| Long-Term Debt | $8B | $7B | $6.6B | $6.4B | $7.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.5B | $14.6B | $14.6B | $16.6B | |
| Common Stock | $387.4M | $335.6M | $350.6M | $340.7M | $355.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $4.4B | $4.5B | $4.4B | $4.4B | $3.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$10.8M | -$26.5M | -$26.8M | $28.8M | $32.3M | |
| Total Equity | $4.4B | $4.5B | $4.4B | $4.4B | $3.2B | |
| Total Liabilities and Equity | $18.8B | $19B | $19B | $19B | $19.8B | |
| Cash and Short Terms | $153.1M | $401.8M | $197.6M | $149M | $176.2M | |
| Total Debt | $8.2B | $8B | $8B | $7.2B | $9.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $152.5M | $404.2M | $197.5M | $149.3M | -- | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.2B | $2.5B | $2.6B | $2.7B | -- | |
| Inventory | $341.5M | $374M | $405.1M | $415.3M | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.2B | $3.7B | $3.7B | $3.8B | -- | |
| Property Plant And Equipment | $394.1M | $328M | $270.1M | $214.6M | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $9.9B | $10.2B | $10.2B | $10.3B | -- | |
| Other Intangibles | $4.5B | $4.3B | $4.1B | $4B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $18.7B | $19.2B | $19B | $19B | -- | |
| Accounts Payable | $147.1M | $156.1M | $217.8M | $279.8M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $81.1M | $72.6M | $47.7M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.1B | $6.3B | $7B | $7.2B | -- | |
| Long-Term Debt | -- | $7B | $6.5B | $6.4B | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.6B | $14.6B | $14.6B | -- | |
| Common Stock | $386M | $337.6M | $350.3M | $341.3M | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$10.8M | -$26.6M | -$26.8M | $28.9M | -- | |
| Total Equity | $4.4B | $4.5B | $4.4B | $4.4B | -- | |
| Total Liabilities and Equity | $18.7B | $19.2B | $19B | $19B | -- | |
| Cash and Short Terms | $152.5M | $404.2M | $197.5M | $149.3M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.6B | $2.9B | $3.3B | $3.7B | $4B | |
| Depreciation & Amoritzation | $995.7M | $966.9M | $985.7M | $1B | $991.1M | |
| Stock-Based Compensation | $61.9M | $56.7M | $69.6M | $84.3M | $83M | |
| Change in Accounts Receivable | -$141.7M | -$309.2M | -$29.8M | -$221.1M | -- | |
| Change in Inventories | -$17.9M | -$126.9M | -$111.9M | -$106.1M | -- | |
| Cash From Operations | $2.8B | $3B | $3.1B | $3.4B | $3.8B | |
| Capital Expenditures | $463.5M | $537.1M | $592.9M | $618.5M | $691.9M | |
| Cash Acquisitions | $390.6M | $505M | $165.3M | $254.3M | $384.8M | |
| Cash From Investing | -$555.6M | -$1.1B | -$733.4M | -$783.3M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.2B | $1.3B | $1.4B | $1.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $491.6M | $810.1M | $908.7M | -- | |
| Long-Term Debt Repaid | -$592.9M | -$43.3M | -$1.1B | -$1.3B | -- | |
| Repurchase of Common Stock | $1.4M | $677.5M | $1.1B | $1.4B | $2.1B | |
| Other Financing Activities | -- | -$1.2M | -- | -$1.3M | -- | |
| Cash From Financing | -$2.2B | -$1.6B | -$2.6B | -$2.6B | -$2.7B | |
| Beginning Cash (CF) | $153.1M | $401.8M | $197.6M | $149M | $176.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $34.4M | $272.2M | -$222.5M | -$46M | $15.8M | |
| Ending Cash (CF) | $186.1M | $690M | -$37.3M | $97.9M | $188.1M | |
| Levered Free Cash Flow | $2.3B | $2.5B | $2.5B | $2.8B | $3.1B | |
| Period Ending | 2022-02-14 | 2023-02-14 | 2024-02-14 | 2025-02-14 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.6B | $2.9B | $3.3B | $3.7B | $4.1B | |
| Depreciation & Amoritzation | $995.7M | $962.9M | $986.6M | $1B | $1B | |
| Stock-Based Compensation | $62M | $57.1M | $69.6M | $85.2M | $84.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.8B | $3B | $3.1B | $3.4B | $3.9B | |
| Capital Expenditures | $463.1M | $535.4M | $593.2M | $624.7M | $703M | |
| Cash Acquisitions | $388.4M | $525.7M | $164.3M | $256.9M | $391M | |
| Cash From Investing | -$550.6M | -$1.1B | -$732.5M | -$791.3M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.2B | $1.3B | $1.4B | $1.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $497.6M | $816.7M | $881.1M | -- | |
| Long-Term Debt Repaid | -$602.6M | -$43.8M | -$1.1B | -$1.3B | -- | |
| Repurchase of Common Stock | $1.4M | $688.5M | $1.1B | $1.4B | $2.1B | |
| Other Financing Activities | -- | -- | -- | -$1.3M | -- | |
| Cash From Financing | -$2.2B | -$1.6B | -$2.6B | -$2.7B | -$2.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $33.5M | $258.2M | -$219.6M | -$46.5M | $16.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.3B | $2.5B | $2.5B | $2.8B | $3.1B | |
| Period Ending | 2023-02-14 | 2024-02-14 | 2025-02-14 | 2026-02-14 | 2027-02-14 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get RLXXF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RLXXF
Sector
P/E ratio
21.11x
20.27x
PEG ratio
0.78x
0.19x
P/B ratio
29.35x
1.79x
Price / LTM sales
4.60x
0.87x
Growth Metrics
RLXXF
Sector
Revenue growth
--
4.54%
Earnings growth
--
2.74%
Revenue (5-year growth)
6.75%
4.54%
Earnings forecast
--
$0.33
Profitability
RLXXF
Sector
Profitability FY 2025
$8.1B
$239M
Return on invested capital
19.69%
4.57%
Return on assets
13.2%
3.11%
Return on equity
66.08%
8.06%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Jul
23
Estimated Next Earnings Date
May
14
Balance Sheet
RLXXF
Sector
Total cash
$289.5M
$136.5M
Short term investments
--
$31.1M
Total assets
$19.8B
$1.4B
Long term debt
--
$44.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
